A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
A011202 is permanently closed to new patient pre-registration (OPEN Step 0) and randomization (OPEN Step 1), effective July 1, 2022.
